Blinded Randomized Placebo-Controlled Study Efficacy and Safety of Injectafer in ID Patients With Fibromyalgia
Status:
Completed
Trial end date:
2016-03-01
Target enrollment:
Participant gender:
Summary
This study investigates the efficacy and safety of an IV iron Injectafer in the treatment of
iron deficient patients with fibromyalgia. Eligible subjects will be randomized in a 1:1
ratio to receive Injectafer or Placebo on days 0 and 5. All treated subjects will be followed
for efficacy and safety for 42 days.